Item 2.02. Results of Operations and Financial Condition.

On March 21, 2023, Minerva Surgical, Inc. (the "Company") issued a press release announcing the results of the Company's operations for the fourth quarter and year ended December 31, 2022. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K, including Exhibit 99.1 hereto, is being furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 7.01. Regulation FD Disclosure

On March 21, 2023, the Company issued a press release announcing the appointment of Kaile Zagger as its new Chief Commercial Officer, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits.

Exhibit
  No.     Description

 99.1       Press release of Minerva Surgical, Inc., dated March 21, 2023,
          announcing unaudited fourth quarter and full-year 2022 financial
          results.


 99.2       Press release of Minerva Surgical, Inc., dated March 21, 2023,
          announcing the appointment of Kaile Zagger as its new Chief Commercial
          Officer.
  104     Cover Page Interactive Data File (embedded within the Inline XBRL
          document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses